Zura Bio Ltd (NASDAQ: ZURA) on Tuesday, plunged -8.14% from the previous trading day, before settling in for the closing price of $1.29. Within the past 52 weeks, ZURA’s price has moved between $1.07 and $6.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -14.05%. With a float of $46.35 million, this company’s outstanding shares have now reached $65.30 million.
The firm has a total of 30 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of -2759450.0%, and the pretax margin is -2620150.0%.
Zura Bio Ltd (ZURA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zura Bio Ltd is 32.21%, while institutional ownership is 55.59%. The most recent insider transaction that took place on Nov 25 ’24, was worth 2,734,458. In this transaction Director of this company sold 1,001,633 shares at a rate of $2.73, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director sold 3,800,000 for $2.70, making the entire transaction worth $10,260,000. This insider now owns 1,001,633 shares in total.
Zura Bio Ltd (ZURA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.05% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Zura Bio Ltd (ZURA) is currently performing well based on its current performance indicators. A quick ratio of 9.16 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.75 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Analysing the last 5-days average volume posted by the [Zura Bio Ltd, ZURA], we can find that recorded value of 0.42 million was better than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 19.91%. Additionally, its Average True Range was 0.15.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 3.04%, which indicates a significant decrease from 23.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 126.97% in the past 14 days, which was higher than the 101.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4434, while its 200-day Moving Average is $3.0063. Now, the first resistance to watch is $1.2633. This is followed by the second major resistance level at $1.3417. The third major resistance level sits at $1.4133. If the price goes on to break the first support level at $1.1133, it is likely to go to the next support level at $1.0417. Now, if the price goes above the second support level, the third support stands at $0.9633.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
Market capitalization of the company is 81.02 million based on 65,294K outstanding shares. Right now, sales total 0 K and income totals -45,390 K. The company made 0 K in profit during its latest quarter, and -9,050 K in sales during its previous quarter.
